Skip to main content
. 2015 Jan 15;5(2):756–771.

Table 4.

Univariate and multivariate analysis of factors associated with HCC recurrence in HBeAg negative patients with low viral load

Factor n Recurrence rate (%) Univariate analysis (p value) Multivariate Analyses (p value) Hazard ratio 95% CI

1-year 3-year
Gender 0.331 NA NA NA
    Male 253 24.5 43.5
    Female 50 16.0 40.0
Age 0.670 NA NA NA
    < 50 118 22.9 39.8
    50-59 105 24.8 45.7
    ≥ 60 80 21.3 43.8
Cirrhosis 0.098 0.075 1.550 0.957-2.509
    Yes 170 24.7 47.6
    No 133 21.1 36.8
Diabetes 0.001 0.188 1.649 0.783-3.472
    Yes 13 15.4 84.6
    No 290 23.4 41.0
Serum HBsAg level (S/CO) 0.014 0.107 1.549 0.910-2.638
    < 2000 84 19.0 31.0
    ≥ 2000 219 24.7 47.5
Serum HBV DNA level (IU/ml) 0.550 NA NA NA
    < 1000 273 23.1 42.5
    1000-1999 30 23.3 46.7
ALT (U/L) 0.186 NA NA NA
    ≤ 41 228 23.7 40.4
    > 41 75 21.3 50.7
AST (U/L) 0.045 0.483 0.818 0.465-1.436
    ≤ 37 226 20.4 39.8
    > 37 77 31.2 51.9
TBIL (μmol/L) 0.918 NA NA NA
    ≤ 18.8 252 22.2 43.3
    > 18.8 51 27.5 41.2
γ-GT (U/L) < 0.001 0.001 2.346 1.430-3.849
    ≤ 61 181 17.1 30.4
    > 61 122 32.0 61.5
ALP (U/L) 0.103 NA NA NA
    ≤ 129 269 21.9 41.6
    > 129 34 32.4 52.9
AFP (μg/L) 0.140 NA NA NA
    ≤ 20 135 14.8 40.0
    > 20 168 29.8 45.2
ALB (g/L) 0.285 NA NA NA
    < 34 2 0.0 0.0
    ≥ 34 301 23.3 43.2
Prealbumin (mg/L) 0.006 0.383 1.265 0.746-2.147
    < 170 59 35.6 57.6
    ≥ 170 244 20.1 39.3
PT (s) 0.392 NA NA NA
    ≤ 13 270 21.9 42.2
    > 13 33 33.3 48.5
WBC (*109/L) 0.825 NA NA NA
    < 4 51 25.5 45.1
    ≥ 4 252 22.6 42.5
PLT (*109/L) 0.805 NA NA NA
    < 100 44 25.0 45.5
    ≥ 100 259 22.8 42.5
Tumor number < 0.001 0.941 1.020 0.606-1.716
    single 250 19.2 38.4
    multiple 53 41.5 64.2
Tumor size (cm) < 0.001 0.230 1.178 0.901-1.541
    ≤ 3 95 8.4 30.5
    3~5 99 20.2 39.4
    5~10 82 35.4 56.1
    > 10 27 48.1 59.3
Capsule formation 0.002 0.007 0.488 0.291-0.819
    Yes 244 20.9 39.8
    No 59 32.2 55.9
Edmonson grading 0.071 0.649 0.897 0.563-1.431
    I 6 16.7 33.3
    II 70 10.0 32.9
    III 216 25.9 45.4
    IV 11 54.5 63.6
Portal vein invasion < 0.001 0.812 1.080 0.571-2.043
    Yes 29 55.2 79.3
    No 274 19.7 39.1
Microvascular invasion < 0.001 0.001 2.215 1.367-3.589
    Yes 104 42.3 58.7
    No 199 13.1 34.7
Cutting margin (cm) (n = 224)a 0.004 0.067 0.470 0.210-1.055
    < 1 187 25.7 45.5
    ≥ 1 37 10.8 18.9

HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B e antigen; WBC, white blood cell; PLT, platelet; AFP, alpha-fetoprotein; TBIL, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALB, albumin; PT, prothrombin time; γ-GT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase.

a

Number of available data.